352 related articles for article (PubMed ID: 22007292)
1. p53 Family: Role of Protein Isoforms in Human Cancer.
Wei J; Zaika E; Zaika A
J Nucleic Acids; 2012; 2012():687359. PubMed ID: 22007292
[TBL] [Abstract][Full Text] [Related]
2. Uncovering the role of p53 splice variants in human malignancy: a clinical perspective.
Surget S; Khoury MP; Bourdon JC
Onco Targets Ther; 2013 Dec; 7():57-68. PubMed ID: 24379683
[TBL] [Abstract][Full Text] [Related]
3. Downregulation of splicing factor SRSF3 induces p53β, an alternatively spliced isoform of p53 that promotes cellular senescence.
Tang Y; Horikawa I; Ajiro M; Robles AI; Fujita K; Mondal AM; Stauffer JK; Zheng ZM; Harris CC
Oncogene; 2013 May; 32(22):2792-8. PubMed ID: 22777358
[TBL] [Abstract][Full Text] [Related]
4. The p53 gene family in vertebrates: Evolutionary considerations.
Biscotti MA; Barucca M; Carducci F; Forconi M; Canapa A
J Exp Zool B Mol Dev Evol; 2019 Sep; 332(6):171-178. PubMed ID: 31046194
[TBL] [Abstract][Full Text] [Related]
5. Transdominant DeltaTAp73 isoforms are frequently up-regulated in ovarian cancer. Evidence for their role as epigenetic p53 inhibitors in vivo.
Concin N; Becker K; Slade N; Erster S; Mueller-Holzner E; Ulmer H; Daxenbichler G; Zeimet A; Zeillinger R; Marth C; Moll UM
Cancer Res; 2004 Apr; 64(7):2449-60. PubMed ID: 15059898
[TBL] [Abstract][Full Text] [Related]
6. TP63 and TP73 in cancer, an unresolved "family" puzzle of complexity, redundancy and hierarchy.
Costanzo A; Pediconi N; Narcisi A; Guerrieri F; Belloni L; Fausti F; Botti E; Levrero M
FEBS Lett; 2014 Aug; 588(16):2590-9. PubMed ID: 24983500
[TBL] [Abstract][Full Text] [Related]
7. TP53 family members and human cancers.
Bénard J; Douc-Rasy S; Ahomadegbe JC
Hum Mutat; 2003 Mar; 21(3):182-91. PubMed ID: 12619104
[TBL] [Abstract][Full Text] [Related]
8. The Nonstructural NS1 Protein of Influenza Viruses Modulates
Dubois J; Traversier A; Julien T; Padey B; Lina B; Bourdon JC; Marcel V; Boivin G; Rosa-Calatrava M; Terrier O
J Virol; 2019 Apr; 93(7):. PubMed ID: 30651364
[TBL] [Abstract][Full Text] [Related]
9. p73 in apoptosis.
Stiewe T; Pützer BM
Apoptosis; 2001 Dec; 6(6):447-52. PubMed ID: 11595834
[TBL] [Abstract][Full Text] [Related]
10. Clinical implications of the deregulated TP73 isoforms expression in cancer.
Rodríguez N; Peláez A; Barderas R; Domínguez G
Clin Transl Oncol; 2018 Jul; 20(7):827-836. PubMed ID: 29230693
[TBL] [Abstract][Full Text] [Related]
11. p53/p73 Protein Network in Colorectal Cancer and Other Human Malignancies.
Horvat A; Tadijan A; Vlašić I; Slade N
Cancers (Basel); 2021 Jun; 13(12):. PubMed ID: 34207603
[TBL] [Abstract][Full Text] [Related]
12. Role of p53 isoforms and aggregations in cancer.
Kim S; An SS
Medicine (Baltimore); 2016 Jun; 95(26):e3993. PubMed ID: 27368003
[TBL] [Abstract][Full Text] [Related]
13. The TP73 complex network: ready for clinical translation in cancer?
Soldevilla B; Millán CS; Bonilla F; Domínguez G
Genes Chromosomes Cancer; 2013 Nov; 52(11):989-1006. PubMed ID: 23913810
[TBL] [Abstract][Full Text] [Related]
14. Regulating p73 isoforms in human tumours.
Coates PJ
J Pathol; 2006 Dec; 210(4):385-9. PubMed ID: 17044134
[TBL] [Abstract][Full Text] [Related]
15. The expression of TA and DeltaNp63 are regulated by different mechanisms in liver cells.
Petitjean A; Cavard C; Shi H; Tribollet V; Hainaut P; Caron de Fromentel C
Oncogene; 2005 Jan; 24(3):512-9. PubMed ID: 15543231
[TBL] [Abstract][Full Text] [Related]
16. The role of the TP73 gene and its transcripts in neuro-oncology.
Jancalek R
Br J Neurosurg; 2014 Oct; 28(5):598-605. PubMed ID: 24742294
[TBL] [Abstract][Full Text] [Related]
17. Regulation of the interferon-gamma (IFN-γ) pathway by p63 and Δ133p53 isoform in different breast cancer subtypes.
Mehta SY; Morten BC; Antony J; Henderson L; Lasham A; Campbell H; Cunliffe H; Horsfield JA; Reddel RR; Avery-Kiejda KA; Print CG; Braithwaite AW
Oncotarget; 2018 Jun; 9(49):29146-29161. PubMed ID: 30018742
[TBL] [Abstract][Full Text] [Related]
18. The isoforms of the p53 protein.
Khoury MP; Bourdon JC
Cold Spring Harb Perspect Biol; 2010 Mar; 2(3):a000927. PubMed ID: 20300206
[TBL] [Abstract][Full Text] [Related]
19. Expression of full-length p53 and its isoform Deltap53 in breast carcinomas in relation to mutation status and clinical parameters.
Baumbusch LO; Myhre S; Langerød A; Bergamaschi A; Geisler SB; Lønning PE; Deppert W; Dornreiter I; Børresen-Dale AL
Mol Cancer; 2006 Oct; 5():47. PubMed ID: 17054774
[TBL] [Abstract][Full Text] [Related]
20. IAPP-driven metabolic reprogramming induces regression of p53-deficient tumours in vivo.
Venkatanarayan A; Raulji P; Norton W; Chakravarti D; Coarfa C; Su X; Sandur SK; Ramirez MS; Lee J; Kingsley CV; Sananikone EF; Rajapakshe K; Naff K; Parker-Thornburg J; Bankson JA; Tsai KY; Gunaratne PH; Flores ER
Nature; 2015 Jan; 517(7536):626-30. PubMed ID: 25409149
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]